000			01996 a2200517 4500
005			20250515041146.0
264		0	_c20070220
008			200702s 0 0 eng d
022			_a0885-3185
024	7		_a10.1002/mds.21073 _2doi
040			_aNLM _beng _cNLM
100	1		_aVisanji, Naomi P
245	0	0	_aPharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease. _h[electronic resource]
260			_bMovement disorders : official journal of the Movement Disorder Society _cNov 2006
300			_a1879-91 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
650	0	4	_aAmantadine _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xadverse effects
650	0	4	_aApomorphine _xadverse effects
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aCallithrix
650	0	4	_aDisability Evaluation
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aDyskinesia, Drug-Induced _xdrug therapy
650	0	4	_aFemale
650	0	4	_aGrooming _xdrug effects
650	0	4	_aHallucinations _xdrug therapy
650	0	4	_aLevodopa _xadverse effects
650	0	4	_aParkinsonian Disorders _xchemically induced
650	0	4	_aPsychomotor Agitation _xdrug therapy
650	0	4	_aPsychotic Disorders _xdrug therapy
650	0	4	_aStatistics, Nonparametric
650	0	4	_aStereotyped Behavior _xdrug effects
700	1		_aGomez-Ramirez, Jordi
700	1		_aJohnston, Tom H
700	1		_aPires, Donna
700	1		_aVoon, Valerie
700	1		_aBrotchie, Jonathan M
700	1		_aFox, Susan H
773	0		_tMovement disorders : official journal of the Movement Disorder Society _gvol. 21 _gno. 11 _gp. 1879-91
856	4	0	_uhttps://doi.org/10.1002/mds.21073 _zAvailable from publisher's website
999			_c16544150 _d16544150